Cargando…
Microencapsulated Genetically Engineered Lactobacillus plantarum 80 (pCBH1) for Bile Acid Deconjugation and Its Implication in Lowering Cholesterol
Cholesterol is known to be a major risk factor for coronary heart disease (CHD). Current treatments for elevated blood cholesterol include dietary management, regular exercise, and drug therapy with fibrates, bile acid sequestrants, and statins. Such therapies, however, are often suboptimal and carr...
Autores principales: | Jones, Mitchell Lawrence, Chen, Hongmei, Ouyang, Wei, Metz, Terrence, Prakash, Satya |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC545656/ https://www.ncbi.nlm.nih.gov/pubmed/15123889 http://dx.doi.org/10.1155/S1110724304307011 |
Ejemplares similares
-
Lactobacillus plantarum 06CC2 reduces hepatic cholesterol levels and modulates bile acid deconjugation in Balb/c mice fed a high‐cholesterol diet
por: Yamasaki, Masao, et al.
Publicado: (2020) -
Investigation of Microencapsulated BSH Active Lactobacillus in the Simulated Human GI Tract
por: Martoni, Christopher, et al.
Publicado: (2007) -
Erratum of “Investigation of Microencapsulated BSH Active Lactobacillus in the Simulated Human GI Tract”
por: Martoni, Christopher, et al.
Publicado: (2009) -
Microencapsulation of Lactobacillus plantarum DKL 109 using External Ionic Gelation Method
por: Chun, Honam, et al.
Publicado: (2014) -
Deconjugated Bile Salts Produced by Extracellular Bile-Salt Hydrolase-Like Activities from the Probiotic Lactobacillus johnsonii La1 Inhibit Giardia duodenalis In vitro Growth
por: Travers, Marie-Agnès, et al.
Publicado: (2016)